Skip to main content

Prokidney Corp.

PROK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001850270

In the last 90 days, Prokidney Corp. insiders filed 0 open-market purchases and 1 sale; 90 institutions reported holding it in 13F filings for Q3 2026, worth $92.0M in total; no superinvestor holds it.

Key figures

Market capNo recent share count in SEC filings
–
Insider buysOpen market, last 90 days
0
Insider sellsLast 90 days, $1.07M in total
1
13F holdersQ3 2026, +20 vs. previous quarter
90
13F valueReported value at the end of Q3 2026
$92.0M
Superinvestors holdingAt the end of Q3 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
$893.0K
+1,075.0% year over year
Net income, FY2025
-$69.0M
No comparable prior period
Free cash flow, FY2025
-$135.3M
No comparable prior period
Revenue, Q3 FY2026
$174.0K
−19.8% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2025: $69.0M (7725.2% of revenue).

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
24.3M
Shares sold short
Change
−230.2K
−0.9% vs. previous
Days to cover
22.51
At average daily volume

Superinvestors holding PROK, Q3 2026

Go to the superinvestors tab

No superinvestor reported holding PROK at the end of Q3 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Prokidney Corp. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 20, 2026 (view filing)5:00 PM ETAug 18-202 daysPereira Brian JGDirectorSSaleClass A Common Stock−675.2K$1.41−$952.2K−100.0%0 after3 lots
Aug 20, 2026 (view filing)5:00 PM ETAug 18-202 daysPereira Brian JGDirectorSSaleClass A Common Stock−81.9K$1.41−$115.5K−100.0%0 after3 lots
Nov 14, 2025 (view filing)Nov 12-132 daysPereira Brian JGDirectorSSaleClass A Common Stock−757.2K$2.49−$1.88M−100.0%0 after4 lots
Jul 9, 2025 (view filing)Jul 81 dayWeber Darin J.Chief Regulatory OfficerSSaleClass A Common Stock−103.5K$3.02−$312.5K−100.0%0 after10b5-1
Apr 24, 2025 (view filing)Apr 222 daysControl Empresarial de Capitales S.A. de C.V.10% Owner, Other: Add'l Rep. Persons-see Ex.99-1PPurchaseClass A Ordinary Shares (as defined in Exhibit 99.1 hereto)+387.4K$0.71+$275.0K+0.5%73.8M after
Apr 21, 2025 (view filing)Apr 174 daysControl Empresarial de Capitales S.A. de C.V.10% Owner, Other: Add'l Rep. Persons-see Ex.99-1PPurchaseClass A Ordinary Shares (as defined in Exhibit 99.1 hereto)+25.0K$0.75+$18.8K0.0%73.5M after
Apr 18, 2025 (view filing)Apr 162 daysControl Empresarial de Capitales S.A. de C.V.10% Owner, Other: Add'l Rep. Persons-see Ex.99-1PPurchaseClass A Ordinary Shares (as defined in Exhibit 99.1 hereto)+100.0K$0.75+$75.0K+0.1%73.4M after
Apr 16, 2025 (view filing)Apr 14-152 daysControl Empresarial de Capitales S.A. de C.V.10% Owner, Other: Add'l Rep. Persons-see Ex.99-1PPurchaseClass A Ordinary Shares (as defined in Exhibit 99.1 hereto)+736.1K$0.7109+$523.3K+1.0%73.3M after2 lots
Apr 14, 2025 (view filing)Apr 10-114 daysControl Empresarial de Capitales S.A. de C.V.10% Owner, Other: Add'l Rep. Persons-see Ex.99-1PPurchaseClass A Ordinary Shares (as defined in Exhibit 99.1 hereto)+1.03M$0.61+$630.8K+1.4%72.6M after2 lots
Sep 20, 2024 (view filing)Sep 191 dayWeber Darin J.Chief Regulatory OfficerSSaleClass A Ordinary Shares−16.4K$2.50−$41.0K−13.7%103.5K after10b5-1

Top 10 13F holders, Q3 2026

See all 90 holders

The largest institutional positions in Prokidney Corp. at the end of Q3 2026; share changes are against Q2 2026.

Institutions holding PROK in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Suvretta Capital Management, LLC12,341,266$20.5M0.56%00.0%Unchanged
Morgan Stanley9,850,142$16.4M0.00%−4,0360.0%Reduced
BlackRock, Inc.7,971,695$13.2M0.00%+2,774,468+53.4%Added
Geode Capital Management, LLC3,590,979$5.96M0.00%+1,200,832+50.2%Added
Propel Bio Management, LLC2,009,733$3.34M1.77%+2,009,733New
Bleichroeder LP1,900,000$3.15M0.31%−100,000−5.0%Reduced
State Street Corp1,810,345$3.01M0.00%+764,400+73.1%Added
Hennion & Walsh Asset Management, Inc.1,806,553$3.00M0.09%−41,196−2.2%Reduced
Vanguard Capital Management LLC1,726,762$2.87M0.00%+551,505+46.9%Added
Charles Schwab Investment Management Inc1,354,874$2.25M0.00%+573,145+73.3%Added

Holders of 5% or more of PROK

See all 2 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Prokidney Corp..

Largest holders of PROK from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Tolerantia, LLC13D/A36.50%106.9M shares−1.50 ppfrom 38.00%Jul 22, 20226 filingsJun 5, 2025SEC
Control Empresarial de Capitales S.A. de C.V.13D/A36.00%73.8M shares–Jul 22, 20223 filingsApr 30, 2026SEC